Sign In
Buy MCFT
$22.71
-0.500 (-2.15%)
At Close: Jun 03, 2026
3 Stocks to Buy for This Tough-as-Nails Market
06:07am, Thursday, 10'th Aug 2023
Let's face it, it's a tough market out there. Investors aren't out of the woods yet despite the recovery and recent S&P 500 and Nasdaq rally this year.
MasterCraft Boat (MCFT) Unveils New Product Line for 2024
12:09pm, Thursday, 20'th Jul 2023
MasterCraft Boat's (MCFT) focus on MasterCraft Segment bodes well, unveils extensive product lineup and enhancements for its 2024 Models.
The 3 Best Consumer Cyclical Stocks to Buy Now
04:38pm, Monday, 26'th Jun 2023
At first glance, the thought of acquiring discretionary retail plays – even the ones labeled as the best consumer cyclical stocks – may seem daunting. Sure, the May jobs report came in much hotter
U.S. stocks closed slightly lower on Friday, with the Dow and S&P 500 recording losses for a second straight week.
MasterCraft Boat Holdings, Inc. (MCFT) Q3 Earnings and Revenues Beat Estimates
10:41am, Wednesday, 10'th May 2023
MasterCraft Boat Holdings, Inc. (MCFT) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.21 per share a year
MasterCraft Boat stocks rises after earnings beat analyst forecast and raises outlook
08:18am, Wednesday, 10'th May 2023
MasterCraft Boat Holdings Inc.'s stock MCFT is up 4.3% after the boat builder's earnings and revenue beat analyst forecasts. MasterCraft said its third-quarter net income rose to $22.51 million or $1.
7 Small-Cap Stocks with Huge Growth Potential
06:15pm, Thursday, 04'th May 2023
While common sense dictates that a healthy portfolio should be geared toward large-capitalization equities, the best small-cap stocks to buy offer something that big boys usually can't: a favorable �
MasterCraft Boat: Acquisitions Creating Diversified Growth
10:56am, Monday, 01'st May 2023
MasterCraft has been able to outperform the broader market in recent years displaying its ability to grow and succeed. I believe MasterCraft's targeted acquisitions will expand its customer base and i
MasterCraft Boat Holdings, Inc. to Webcast Fiscal Third Quarter 2023 Earnings Conference Call Wednesday, May 10, 2023
10:18am, Thursday, 27'th Apr 2023
VONORE, Tenn., April 27, 2023 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) will host a live webcast of its fiscal third quarter 2023 earnings conference call
3 Leisure & Recreation Products Stocks to Watch Despite Industry Woes
12:10pm, Monday, 03'rd Apr 2023
Inflation and economic woes hurt the Leisure & Recreation Products industry. However, stocks like ASO, GOLF and MCFT appear better positioned to escape industry challenges.
Is MasterCraft Boat (MCFT) a Great Value Stock Right Now?
11:27am, Friday, 24'th Mar 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
7 Value Stocks Worth Buying at These 52-Week Highs
03:46pm, Wednesday, 22'nd Mar 2023
With the market still digesting the tremors of the banking sector fallout, investors may want to consider compelling value stocks to buy, even those trading near their 52-week highs. True, investors o
MASTERCRAFT BOAT HOLDINGS, INC. (MCFT) Hits Fresh High: Is There Still Room to Run?
10:39am, Thursday, 09'th Mar 2023
MasterCraft Boat Holdings, Inc. (MCFT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Value Investors Buy MasterCraft Boat (MCFT) Stock?
11:17am, Wednesday, 08'th Mar 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
3 Reasons Why Growth Investors Shouldn't Overlook MasterCraft Boat Holdings, Inc. (MCFT)
02:18pm, Friday, 03'rd Mar 2023
MasterCraft Boat Holdings, Inc. (MCFT) possesses solid growth attributes, which could help it handily outperform the market.
